EP 1515982 A4 20051026 - COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
Title (en)
COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR THERAPIE UND DIAGNOSE VON PROSTATAKREBS
Title (fr)
METHODES ET COMPOSITIONS POUR LA THERAPIE ET LE DIAGNOSTIC DU CANCER DE LA PROSTATE
Publication
Application
Priority
- US 0214753 W 20020509
- US 85291101 A 20010509
- US 89581401 A 20010629
- US 1289601 A 20011210
Abstract (en)
[origin: WO02089747A2] Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.
IPC 1-7
IPC 8 full level
G01N 33/53 (2006.01); A61K 31/7088 (2006.01); A61K 35/12 (2006.01); A61K 35/14 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61P 13/08 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C07K 16/30 (2006.01); C07K 16/32 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/07 (2010.01); C12N 5/0783 (2010.01); C12N 5/09 (2010.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12Q 1/68 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
A61K 39/4611 (2023.05); A61K 39/4632 (2023.05); A61K 39/464494 (2023.05); A61P 13/08 (2018.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); C07K 14/47 (2013.01); C07K 16/3069 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/34 (2013.01); C07K 2319/00 (2013.01)
Citation (search report)
- [X] WO 9850567 A1 19981112 - ABBOTT LAB [US]
- [X] WO 0125272 A2 20010412 - CORIXA CORP [US], et al
- [PX] WO 0173032 A2 20011004 - CORIXA CORP [US], et al
Citation (examination)
- WO 0004149 A2 20000127 - CORIXA CORP [US]
- WO 9967384 A2 19991229 - INCYTE PHARMA INC [US], et al
- WO 0151633 A2 20010719 - CORIXA CORP [US], et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02089747 A2 20021114; WO 02089747 A3 20041229; CA 2446788 A1 20021114; EP 1515982 A2 20050323; EP 1515982 A4 20051026; EP 1988097 A1 20081105; JP 2005504513 A 20050217
DOCDB simple family (application)
US 0214753 W 20020509; CA 2446788 A 20020509; EP 02725984 A 20020509; EP 08011769 A 20020509; JP 2002586886 A 20020509